Investigación / Grupos de investigación

Grupo  2

Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Publicaciones (854)

  • Sartore-Bianchi, A; Garcia-Alfonso, P; Geissler, M; Kohne, CH; Peeters, M; Price, T; Valladares-Ayerbes, M; Zhang, Y; Burdon, P; Taieb, J; Modest, DP.

    Relationships Between Kohne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer

    CLINICAL COLORECTAL CANCER. 2021; 20(4): 305-313 Nº de citas: 3 [doi:10.1016/j.clcc.2021.05.007]

  • Harbeck, N; Rastogi, P; Martin, M; Tolaney, SM; Shao, ZM; Fasching, PA; Huang, CS; Jaliffe, GG; Tryakin, A; Goetz, MP; Rugo, HS; Senkus, E; Testa, L; Andersson, M; Tamura, K; Del Mastro, L; Steger, GG; Kreipe, H; Hegg, R; Sohn, J; Guarneri, V; Cortes, J; Hamilton, E; Andre, V; Wei, R; Barriga, S; Sherwood, S; Forrester, T; Munoz, M; Shahir, A; San Antonio, B; Nabinger, SC; Toi, M; Johnston, SRD; O'Shaughnessy, J; monarchE Comm Members.

    Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

    ANNALS OF ONCOLOGY. 2021; 32(12): 1571-1581 Nº de citas: 279 [doi:10.1016/j.annonc.2021.09.015]

  • Moura, DS; Pena-Chilet, M; Varela, JAC; Alvarez-Alegret, R; Agra-Pujol, C; Izquierdo, F; Ramos, R; Ortega-Medina, L; Martin-Davila, F; Castilla-Ramirez, C; Hernandez-Leon, CN; Romagosa, C; Salgado, MAV; Lavernia, J; Bague, S; Mayodormo-Aranda, E; Vicioso, L; Barcelo, JEH; Rubio-Casadevall, J; de Juan, A; Fiano-Valverde, MC; Hindi, N; Lopez-Alvarez, M; Lacerenza, S; Dopazo, J; Gutierrez, A; Alvarez, R; Valverde, C; Martinez-Trufero, J; Martin-Broto, J.

    A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin

    MOLECULAR ONCOLOGY. 2021; 15(12): 3691-3705 Nº de citas: 10 [doi:10.1002/1878-0261.12996]

  • Untch, M; Martin, M; de Laurentiis, M; Gligorov, J.

    How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer

    Oncology And Therapy. 2021; 9(2): 297-309 Nº de citas: 2 [doi:10.1007/s40487-021-00153-5]

  • Bastos-Oreiro, M; Ortiz, J; Pradillo, V; Salas, E; Marinez-Laperche, C; Munoz, A; Buno, I; Diez-Martin, JL; Soria, JM; Izquierdo, CP.

    Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma

    Cancer Medicine. 2021; 10(21): 7585-7592 Nº de citas: 8 [doi:10.1002/cam4.4280]

  • Maraveyas, A; Kraaijpoel, N; Bozas, G; Huang, C; Mahe, I; Bertoletti, L; Bartels-Rutten, A; Beyer-Westendorf, J; Constans, J; Iosub, D; Couturaud, F; Munoz, AJ; Biosca, M; Lerede, T; van Es, N; Di Nisio, M; UPE Investigators.

    The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

    JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2021; 19(11): 2791-2800 Nº de citas: 7 [doi:10.1111/jth.15489]

  • Donat-Vargas, C; Guerrero-Zotano, A; Casas, A; Baena-Canada, JM; Lope, V; Antolin, S; Garcia-Saenz, JA; Bermejo, B; Munoz, M; Ramos, M; de Juan, A; Sanchez, CJ; Sanchez-Rovira, P; Anton, A; Brunet, J; Gavila, J; Salvador, J; Arellano, EA; Bezares, S; de Larrea-Baz, NF; Perez-Gomez, B; Martin, M; Pollan, M.

    Trajectories of alcohol consumption during life and the risk of developing breast cancer

    BRITISH JOURNAL OF CANCER. 2021; 125(8): 1168-1176 Nº de citas: 22 [doi:10.1038/s41416-021-01492-w]

  • Bordonaro, R; Calvo, A; Auriemma, A; Hollebecque, A; Rubovszky, G; Saunders, MP; Papai, Z; Prager, G; Stein, A; Andre, T; Argiles, G; Cubillo, A; Dahan, L; Edeline, J; Leger, C; Cattan, V; Fougeray, R; Amellal, N; Tabernero, J.

    Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study

    Esmo Open. 2021; 6(5): 100270-100270 Nº de citas: 6 [doi:10.1016/j.esmoop.2021.100270]

  • Kahan, Z; Gil-Gil, M; Ruiz-Borrego, M; Carrasco, E; Ciruelos, E; Munoz, M; Bermejo, B; Margeli, M; Anton, A; Casas, M; Csoszi, T; Murillo, L; Morales, S; Calvo, L; Lang, I; Alba, E; de la Haba-Rodriguez, J; Ramos, M; Lopez, IA; Gal-Yam, E; Garcia-Palomo, A; Alvarez, E; Gonzalez-Santiago, S; Rodriguez, CA; Servitja, S; Corsaro, M; Rodrigalvarez, G; Zielinski, C; Martin, M.

    Original Research Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study

    EUROPEAN JOURNAL OF CANCER. 2021; 156: 70-82 Nº de citas: 12 [doi:10.1016/j.ejca.2021.07.004]

  • De Laurentiis, M; Borstnar, S; Campone, M; Warner, E; Bofill, JS; Jacot, W; Dent, S; Martin, M; Ring, AL; Cottu, P; Lu, JI; Ciruelos, E; Azim, HA; Chatterjee, S; Zhou, KT; Wu, JW; Menon-Singh, L; Zamagni, C.

    Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population

    BREAST CANCER RESEARCH AND TREATMENT. 2021; 189(3): 689-699 Nº de citas: 25 [doi:10.1007/s10549-021-06334-0]

  • Alvarez, YE; Carpeno, JD; Bell, D; Drago, A; Franceschetti, A.

    Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain

    CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(10): 2155-2162 Nº de citas: 3 [doi:10.1007/s12094-021-02623-8]

  • Bockorny, B; Macarulla, T; Semenisty, V; Borazanci, E; Feliu, J; Ponz-Sarvise, M; Abad, DG; Oberstein, P; Alistar, A; Munoz, A; Geva, R; Guillen-Ponce, C; Fernandez, MS; Peled, A; Chaney, M; Gliko-Kabir, I; Shemesh-Darvish, L; Ickowicz, D; Sorani, E; Kadosh, S; Vainstein-Haras, A; Hidalgo, M.

    Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

    CLINICAL CANCER RESEARCH. 2021; 27(18): 5020-5027 Nº de citas: 55 [doi:10.1158/1078-0432.CCR-21-0929]

  • Cabezon-Gutierrez, L; Custodio-Cabello, S; Palka-Kotlowska, M; Alonso-Viteri, S; Khosravi-Shahi, P.

    Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1

    CLINICAL LUNG CANCER. 2021; 22(5): 381-389 Nº de citas: 6 [doi:10.1016/j.cllc.2021.03.006]

  • Garcia-Alfonso, P; Munoz, A; Jimenez-Castro, J; Jimenez-Fonseca, P; Pericay, C; Longo-Munoz, F; Reyna-Fortes, C; Argiles-Martinez, G; Gonzalez-Astorga, B; Gomez-Reina, MJ; Ruiz-Casado, A; Rodriguez-Salas, N; Lopez-Lopez, R; Carmona-Bayonas, A; Conde-Herrero, V; Aranda, E.

    Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study

    Cancers. 2021; 13(18): Nº de citas: 8 [doi:10.3390/cancers13184514]

  • Ramos-Medina, R; Lopez-Tarruella, S; Del Monte-Millan, M; Massarrah, T; Martin, M.

    Technical Challenges for CTC Implementation in Breast Cancer

    Cancers. 2021; 13(18): Nº de citas: 13 [doi:10.3390/cancers13184619]

  • Schettini, F; Giuliano, M; Lambertini, M; Bartsch, R; Pinato, DJ; Onesti, CE; Harbeck, N; Luftner, D; Rottey, S; van Dam, PA; Zaman, K; Mustacchi, G; Gligorov, J; Awada, A; Campone, M; Wildiers, H; Gennari, A; Tjan-Heijnen, VCG; Cortes, J; Locci, M; Paris, I; Del Mastro, L; De Placido, S; Martin, M; Jerusalem, G; Venturini, S; Curigliano, G; Generali, D.

    Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

    Cancers. 2021; 13(17): Nº de citas: 10 [doi:10.3390/cancers13174421]

  • Martinez-Trufero, J; Jurado, JC; Gomez-Mateo, MC; Bernabeu, D; Floria, LJ; Lavernia, J; Sebio, A; del Muro, XG; Alvarez, R; Correa, R; Hernandez-Leon, CN; Marquina, G; Hindi, N; Redondo, A; Martinez, V; Asencio, JM; Mata, C; Morales, CMV; Martin-Broto, J.

    Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS - GROUP). Part I

    CANCER TREATMENT REVIEWS. 2021; 99: 102259-102259 Nº de citas: 6 [doi:10.1016/j.ctrv.2021.102259]

  • Martinez-Trufero, J; Jurado, JC; Hernandez-Leon, CN; Correa, R; Asencio, JM; Bernabeu, D; Alvarez, R; Hindi, N; Mata, C; Marquina, G; Martinez, V; Redondo, A; Floria, LJ; Gomez-Mateo, MC; Lavernia, J; Sebio, A; del Muro, XG; Martin-Broto, J; Valverde-Morales, C.

    Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II

    CANCER TREATMENT REVIEWS. 2021; 99: 102260-102260 Nº de citas: 9 [doi:10.1016/j.ctrv.2021.102260]